NARI vs. ICUI, TNDM, IART, PRCT, ATEC, LMAT, NVCR, ATRC, IRTC, and AXNX
Should you be buying Inari Medical stock or one of its competitors? The main competitors of Inari Medical include ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Integra LifeSciences (IART), PROCEPT BioRobotics (PRCT), Alphatec (ATEC), LeMaitre Vascular (LMAT), NovoCure (NVCR), AtriCure (ATRC), iRhythm Technologies (IRTC), and Axonics (AXNX). These companies are all part of the "surgical & medical instruments" industry.
ICU Medical (NASDAQ:ICUI) and Inari Medical (NASDAQ:NARI) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends.
ICU Medical has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, Inari Medical has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.
Inari Medical has lower revenue, but higher earnings than ICU Medical. Inari Medical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Inari Medical had 10 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for Inari Medical and 3 mentions for ICU Medical. Inari Medical's average media sentiment score of 0.37 beat ICU Medical's score of 0.19 indicating that ICU Medical is being referred to more favorably in the media.
96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 91.0% of Inari Medical shares are owned by institutional investors. 6.7% of ICU Medical shares are owned by insiders. Comparatively, 10.6% of Inari Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
ICU Medical received 328 more outperform votes than Inari Medical when rated by MarketBeat users. However, 67.90% of users gave Inari Medical an outperform vote while only 64.48% of users gave ICU Medical an outperform vote.
Inari Medical has a net margin of -0.33% compared to Inari Medical's net margin of -1.31%. Inari Medical's return on equity of 6.35% beat ICU Medical's return on equity.
ICU Medical currently has a consensus target price of $123.00, indicating a potential upside of 26.93%. Inari Medical has a consensus target price of $73.71, indicating a potential upside of 90.77%. Given ICU Medical's higher possible upside, analysts clearly believe Inari Medical is more favorable than ICU Medical.
Summary
Inari Medical beats ICU Medical on 10 of the 18 factors compared between the two stocks.
Get Inari Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NARI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inari Medical Competitors List
Related Companies and Tools
